Search Our Site

Search Results

346 Results Found

Supervised injection bill dead for year

  • NEWS
  • by Liz Highleyman
  • Jun 26, 2019

State legislation to allow a pilot supervised injection facility in San Francisco will not be debated in the Senate this year, the bill's co-sponsors have announced.

Guidance will mandate insurance coverage for PrEP

  • NEWS
  • by Liz Highleyman
  • Jun 12, 2019

The U.S. Preventive Services Task Force released a recommendation Tuesday, calling on health care providers to offer PrEP to men and women at high risk of acquiring HIV.

St. James Infirmary celebrates 20 years

  • NEWS
  • by Liz Highleyman
  • May 22, 2019

St. James Infirmary, San Francisco's peer-based clinic for sex workers, will celebrate its first two decades with a gala at Terra Gallery Sunday, June 2.

Study confirms no transmissions with undetectable HIV

  • NEWS
  • by Liz Highleyman
  • May 20, 2019

The largest treatment-as-prevention study for gay and bisexual men confirms that people on antiretroviral therapy with undetectable viral load do not transmit HIV.

Jones receives Cuba award amid cancellation of Pride events

  • NEWS
  • by Liz Highleyman
  • May 13, 2019

San Francisco AIDS activist Cleve Jones received an award from the Cuban National Center for Sexual Education in Havana last weekend as other activists were reportedly arrested after attempting an alternative march after the government canceled two others

Advocates say CDC has PrEP patents

  • NEWS
  • by Liz Highleyman
  • Apr 24, 2019

The Centers for Disease Control and Prevention holds patents on the use of Truvada for HIV prevention, according to advocates, who want Gilead Sciences to pay future and retroactive royalties to make PrEP more widely available.

FDA approves new dual combo pill for HIV

  • NEWS
  • by Liz Highleyman
  • Apr 10, 2019

The U.S. Food and Drug Administration this week approved Dovato, a two-drug combination pill that provides a complete once-daily antiretroviral regimen for people starting HIV treatment for the first time.

On-demand PrEP failure reported

  • NEWS
  • by Liz Highleyman
  • Mar 27, 2019

An Australian man said he acquired HIV while taking on-demand PrEP before and after sex, which could represent the latest in a handful of cases of failure of the prevention pill.

Gaps in testing and treatment spur HIV transmission

  • NEWS
  • by Liz Highleyman
  • Mar 27, 2019

Around 80 percent of new HIV infections are attributable to people who either do not know their status or are not receiving treatment to suppress viral load, according to a new report from the Centers for Disease Control and Prevention.

Project Inform has closed, sources say

  • NEWS
  • by Liz Highleyman
  • Mar 20, 2019

Project Inform, one of the nation's longest-running HIV education and advocacy organizations, has terminated its staff and dissolved, according to former staff members and others.

PrEP research highlighted at confab

  • NEWS
  • by Liz Highleyman
  • Mar 20, 2019

PrEP was a major topic at the Conference on Retroviruses and Opportunistic Infections this month in Seattle. Researchers showed that a new version of tenofovir works as well as the Truvada pill and offered insights about how gay and bisexual men are using

Project Inform expected to close

  • NEWS
  • by Liz Highleyman
  • Mar 15, 2019

Project Inform, one of the nation's longest-running HIV education and advocacy organizations, has terminated its staff and is likely to cease operations, the Bay Area Reporter has learned.

Trump budget mixed on HIV

  • NEWS
  • by Liz Highleyman
  • Mar 13, 2019

President Donald Trump proposed a budget for fiscal year 2020 Monday that includes new funding for an initiative to end HIV in the United States but also contains cuts that could compromise that goal, advocates said.

HIV case may be a second cure

  • NEWS
  • by Liz Highleyman
  • Mar 6, 2019

A London man with long-term undetectable HIV despite stopping antiretroviral treatment a year and a half ago could potentially be the second case of an HIV cure, according to a report at the Conference on Retroviruses and Opportunistic Infections.

Fauci touts HIV plan at confab

  • NEWS
  • by Liz Highleyman
  • Mar 6, 2019

Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases fleshed out a proposed national HIV plan at the opening session of the Conference on Retroviruses and Opportunistic Infections this week in Seattle.

Federal suit against Philly safe injection site draws criticism

  • NEWS
  • by Liz Highleyman
  • Feb 13, 2019

The federal government has thrown up another roadblock to supervised injection sites, filing a lawsuit against Philadelphia's Safehouse, which had hoped to open the first such facility in the United States.

Supervised injection bill reintroduced

  • NEWS
  • by Liz Highleyman
  • Feb 6, 2019

Just three months after a stinging veto by former Governor Jerry Brown, two state lawmakers reintroduced a bill that would allow a pilot supervised injection site to open in San Francisco.

Activists plan alternative to AIDS 2020

  • NEWS
  • by Liz Highleyman
  • Dec 12, 2018

Global HIV advocates plan to hold an alternative meeting in Mexico City to coincide with the International AIDS Conference in July 2020, as organizers of that confab decline to move it out of the Bay Area.

Sex worker clinic moves to SF health center

  • NEWS
  • by Liz Highleyman
  • Dec 5, 2018

St. James Infirmary, a peer-based clinic for sex workers and their families, has moved to a new location in the Tenderloin shared with other community health and social services agencies.

New PrEP data show nearly 30 percent rise

  • NEWS
  • by Liz Highleyman
  • Nov 28, 2018

The number of people taking PrEP rose by nearly 30 percent from 2016 to 2017, but disparities remain, according to updated figures released this week by AIDSVu.